How Virax Biolabs is Developing a Potentially Game-Changing Immunology Platform for T-Cell Testing

from Rx for Biotech · host Podcast Host Chris Leidli

In this podcast episode, Tomasz George, Chief Scientific Officer at Virax Biolabs, shares how the company's ViraxImmune™ technology platform will empower patients to take control of their health and make informed decisions on how to respond to current and future viral threats. The company hopes their ViraxImmune™ platform will shift the way individuals are able to manage aspects of their immune health.

Episode metadata supplied by the publisher feed · Published Jul 13, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

How Virax Biolabs is Developing a Potentially Game-Changing Immunology Platform for T-Cell Testing

0:00 21:14

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Wild WinsDay Wild WinsDay Pump the hump with WILD WINSday 🐪💪: Your 3-minute weekly video boost for leadership, sales, marketing, and business breakthroughs to WIN the day!

Frequently Asked Questions

How long is this episode of Rx for Biotech?

This episode is 21 minutes long.

When was this Rx for Biotech episode published?

This episode was published on July 13, 2023.

Can I download this Rx for Biotech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!